InChI=1S/C45H54F2N4O8/c1-8-42-14-11-16-51-17-15-43(36(42)51)30-19-31(34(56-5)20-33(30)49(4)37(43)45(55,40(54)58-7)38(42)59-25(2)52)44(39(53)57-6)21-26-18-27(41(3,46)47)23-50(22-26)24-29-28-12-9-10-13-32(28)48-35(29)44/h9-14,19-20,26-27,36-38,48,55H,8,15-18,21-24H2,1-7H3/t26-,27+,36-,37+,38+,42+,43+,44-,45-/m0/s1 |
NMDYYWFGPIMTKO-KLCPSUAYSA-N |
N12C[C@@](C[C@H](C1)C[C@](C(=O)OC)(C3=C(C=C4C(=C3)[C@]56[C@@H]7[C@]([C@@]([C@@]([C@@]5(N4C)[H])(C(=O)OC)O)([H])OC(C)=O)(C=CCN7CC6)CC)OC)C=8NC=9C(=CC=CC9)C8C2)(C(C)(F)F)[H] |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via alkaloid )
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
methyl (2β,3β,4β,5α,12β,19α)-4-(acetyloxy)-15-[(12S,14S,16R)-16-(1,1-difluoroethyl)-12-(methoxycarbonyl)-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate
|
vinflunina
|
WHO MedNet
|
vinflunine
|
WHO MedNet
|
vinflunine
|
WHO MedNet
|
vinfluninum
|
WHO MedNet
|
20',20'-difluoro-3',4'-dihydrovinorelbine
|
ChEBI
|
4'-deoxy-20',20'-difluoro-5'-norvincaleukoblastine
|
ChEBI
|
4'-deoxy-20',20'-difluoro-8'-norvincaleukoblastine
|
ChEBI
|
15644716
|
Reaxys Registry Number
|
Reaxys
|
162652-95-1
|
CAS Registry Number
|
ChemIDplus
|
20568834
|
PubMed citation
|
Europe PMC
|
21462785
|
PubMed citation
|
Europe PMC
|
22996801
|
PubMed citation
|
Europe PMC
|
23195794
|
PubMed citation
|
Europe PMC
|
24283925
|
PubMed citation
|
Europe PMC
|
25342282
|
PubMed citation
|
Europe PMC
|
25588192
|
PubMed citation
|
Europe PMC
|
25877096
|
PubMed citation
|
Europe PMC
|
25919319
|
PubMed citation
|
Europe PMC
|
26040470
|
PubMed citation
|
Europe PMC
|
26117277
|
PubMed citation
|
Europe PMC
|
26410730
|
PubMed citation
|
Europe PMC
|
26421462
|
PubMed citation
|
Europe PMC
|
|